Hjem › Diffust stort B-celle lymfom › North Dakota › Fargo
Diffust stort B-celle lymfom kliniske forsøg i Fargo, ND
4 studier for Diffust stort B-celle lymfom søger deltagere på steder i og omkring Fargo (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
RekruttererFase 2
- Essentia Health Cancer Center-South University Clinic, Fargo
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
RekruttererFase 3
- Sanford Health Roger Maris Cancer Center ( Site 0189), Fargo
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
RekruttererFase 1/2
- Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 1003), Fargo
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
RekruttererFase 2
- Sanford Broadway Medical Center, Fargo
- Sanford Roger Maris Cancer Center, Fargo
Diffust stort B-celle lymfom forsøg i andre byer
- New York City, NY21 studier
- Baldwin Park, CA19 studier
- Chicago, IL18 studier
- Houston, TX17 studier
- Los Angeles, CA17 studier
- Boston, MA16 studier
- Milwaukee, WI16 studier
- Nashville, TN15 studier
- Portland, OR15 studier
- Philadelphia, PA15 studier
- Durham, NC14 studier
- Dallas, TX13 studier
Andre studier i Fargo
- Ikke-småcellet lungecancer14 studier
- Lungecancer13 studier
- Kræft (alle typer)10 studier
- Overvægt9 studier
- Melanom9 studier
- Overvægt8 studier
- Prostatakræft8 studier
- Colorektal kræft7 studier
- Brystkræft7 studier
- Pladecellekræft i hoved og hals6 studier
- Bugspytkirtelkræft6 studier
- Rektalcancer6 studier
Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.